News
During a week-long joint operation between U.S. Customs and Border Protection and U.S. Food and Drug Administration, CBP ...
Aug 2, 2025; El Segundo, CA, USA; Los Angeles Lakers Luka Doncic (77) is interviewed Spectrum SportsNet following a press ...
Some GPs are quietly proving that targeted diet and lifestyle programmes can achieve similar results to Mounjaro, Wegovy and ...
In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...
Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...
Novo Nordisk's Canadian patent for weight loss drug Ozempic is set to expire in January 2026. Dr. Justin Ezekowitz discusses generic competitors that may come.
A series of lawsuits have been filed in Marion County court alleging that drug manufacturer Eli Lilly downplayed the side ...
Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...
Katy Perry is showing off her super-slim figure in a tiny bikini on a yacht, but fans think she's gotten too skinny.
A new, late-stage clinical study shows disappointing results for Eli Lilly's weight loss pill Orforglipron. The experimental ...
Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results